Rxsight Inc - Detailed Introduction, Company Background, Business Scope, Financial Data, and Market Performance

More Details of Rxsight Inc Company

RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.

Rxsight Inc Info



Ticker SymbolRXST

Company nameRxsight Inc

IPO dateJul 30, 2021

CEODr. Ron M. Kurtz, M.D.

Number of employees498

Security typeOrdinary Share

Fiscal year-endJul 30

Address100 Columbia Street

CityALISO VIEJO

Stock exchangeNASDAQ Global Market Consolidated

CountryUnited States of America

Postal code92656

Phone19495217822

Websitehttps://www.rxsight.com/

Ticker SymbolRXST

IPO dateJul 30, 2021

CEODr. Ron M. Kurtz, M.D.

Company Executives of Rxsight Inc



Name

Name/Position

Position

Shareholding

Change

Mr. Eric Weinberg

Co-President, Chief Commercial Officer

496.25K

+60.99%

Dr. Ilya Goldshleger, Ph.D.

Co-President, Chief Operating Officer

67.06K

+53.75%

Dr. William J. Link, Ph.D.

Independent Director

59.10K

+22.24%

Mr. Robert J. (Bob) Palmisano

Independent Director

41.04K

+35.50%

Ms. Shelley B. Thunen

Co-President, Chief Financial Officer

38.35K

-1.26%

Ms. Shweta Singh Maniar

Independent Director

18.14K

+145.63%

Dr. Ron M. Kurtz, M.D.

President, Chief Executive Officer, Director

--

Ms. Juliet Tammenoms Bakker

Independent Director

--

Mr. J. Andy Corley

Independent Chairman of the Board

--

Ms. Julie B. Andrews

Independent Director

--

Name

Name/Position

Position

Shareholding

Change

Mr. Eric Weinberg

Co-President, Chief Commercial Officer

496.25K

+60.99%

Dr. Ilya Goldshleger, Ph.D.

Co-President, Chief Operating Officer

67.06K

+53.75%

Dr. William J. Link, Ph.D.

Independent Director

59.10K

+22.24%

Mr. Robert J. (Bob) Palmisano

Independent Director

41.04K

+35.50%

Ms. Shelley B. Thunen

Co-President, Chief Financial Officer

38.35K

-1.26%

Ms. Shweta Singh Maniar

Independent Director

18.14K

+145.63%

Revenue Breakdown

FY2024

No Data

By RegionUSD

Name

Revenue

Proportion

United States

139.93M

0.00%

By Business

By Region

No Data

Shareholding Stats

Updated: Sat, Nov 1

Shareholders

Shareholder Types

Shareholders

Proportion

RA Capital Management, LP

9.01%

BlackRock Institutional Trust Company, N.A.

6.10%

Artisan Partners Limited Partnership

5.48%

Millennium Management LLC

5.33%

The Vanguard Group, Inc.

5.22%

Other

68.86%

Shareholders

Proportion

RA Capital Management, LP

9.01%

BlackRock Institutional Trust Company, N.A.

6.10%

Artisan Partners Limited Partnership

5.48%

Millennium Management LLC

5.33%

The Vanguard Group, Inc.

5.22%

Other

68.86%

Shareholder Types

Shareholders

Proportion

Investment Advisor

37.47%

Hedge Fund

24.29%

Investment Advisor/Hedge Fund

16.39%

Venture Capital

9.21%

Individual Investor

5.62%

Research Firm

5.04%

Pension Fund

1.11%

Private Equity

0.56%

Bank and Trust

0.46%

Institutional Shareholding



Updated: Wed, Oct 1

Reporting Period

No. of institutions

Shares Held

Proportion

Change

2025Q3

449

38.67M

94.05%

-9.26M

2025Q2

446

40.83M

100.45%

-3.67M

2025Q1

453

40.49M

99.79%

-7.96M

2024Q4

440

38.96M

96.23%

-5.07M

2024Q3

420

38.15M

94.75%

-3.92M

2024Q2

391

37.00M

93.42%

-2.64M

2024Q1

338

34.63M

93.15%

-2.60M

2023Q4

299

33.17M

91.51%

-284.01K

2023Q3

253

34.41M

96.36%

-1.84M

2023Q2

214

31.39M

90.12%

+2.22M

Shareholder Activity



Name

Shares Held

Proportion

Change

Chg %

Date

RA Capital Management, LP

3.70M

9.05%

-40.05K

-1.07%

Jun 30, 2025

BlackRock Institutional Trust Company, N.A.

2.51M

6.13%

-48.31K

-1.89%

Jun 30, 2025

Artisan Partners Limited Partnership

2.25M

5.51%

+485.02K

+27.44%

Jun 30, 2025

Millennium Management LLC

2.61M

6.38%

+1.66M

+174.50%

Jul 09, 2025

The Vanguard Group, Inc.

2.27M

5.55%

-113.59K

-4.76%

Jun 30, 2025

D. E. Shaw & Co., L.P.

1.32M

3.23%

+1.30M

+5906.05%

Jun 30, 2025

DWS Investments UK Limited

1.22M

2.99%

+566.62K

+86.54%

Jun 30, 2025

NO STREET GP LP

1.20M

2.93%

+600.00K

+100.00%

Jun 30, 2025

Citadel Advisors LLC

1.03M

2.51%

+797.64K

+346.47%

Jun 30, 2025

State Street Investment Management (US)

916.22K

2.24%

+17.55K

+1.95%

Jun 30, 2025

Related ETFs



Updated: Thu, Nov 6

Name

Proportion

SPDR S&P Health Care Equipment ETF

0.59%

iShares Russell 2000 Growth ETF

0.02%

iShares Morningstar Small-Cap Value ETF

0.01%

iShares Russell 2000 ETF

0.01%

iShares Morningstar Small-Cap ETF

0.01%

WisdomTree US SmallCap Fund

0.01%

ProShares Hedge Replication ETF

0.01%

Schwab U.S. Small-Cap ETF

0.01%

ProShares UltraPro Russell2000

0.01%

Global X Russell 2000 ETF

0.01%

SPDR S&P Health Care Equipment ETF

Proportion0.59%

iShares Russell 2000 Growth ETF

Proportion0.02%

iShares Morningstar Small-Cap Value ETF

Proportion0.01%

iShares Russell 2000 ETF

Proportion0.01%

iShares Morningstar Small-Cap ETF

Proportion0.01%

WisdomTree US SmallCap Fund

Proportion0.01%

ProShares Hedge Replication ETF

Proportion0.01%

Schwab U.S. Small-Cap ETF

Proportion0.01%

ProShares UltraPro Russell2000

Proportion0.01%

Global X Russell 2000 ETF

Proportion0.01%

Dividend



A total of 0.00 USD has been distributed in dividends over the past 5 years.

Date

Dividend

Record Date

Payment Date

Ex-dividend Date

No Data

Stock Split



Date

Type

Ratio

No Data

Date

Type

Ratio

No Data